skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications

(2114) Views  (691) Full article downloads

Authors: Brian C Cumbie, Kathie L Hermayer

Published Date January 2007 Volume 2007:3(6) Pages 823 - 832
DOI: http://dx.doi.org/10.2147/VHRM.S

Brian C Cumbie, Kathie L Hermayer

Division of Endocrinology, Diabetes and Medical Genetics, Medical University of South Carolina, Charleston, South Carolina, USA

Abstract: Microvascular complications characterized by retinopathy, nephropathy, and neuropathy are highly prevalent among diabetics. Glycemic control has long been the mainstay for preventing progression of these complications; however, such control is not easily achieved. Currently, alternative adjunctive approaches to treating and preventing microvascular damage are being undertaken by targeting the molecular pathogenesis of diabetic complications. This review summarizes the specific pathogenic mechanisms of microvascular complications for which clinical therapies have been developed, including the polyol pathway, advanced glycation end products, protein kinase c, vascular epithelium growth factor, and the superoxide pathway. The review further focuses on therapies for these targets that are currently available or are undergoing late-stage clinical trials.

Keywords: diabetes, aldose reductase inhibitor, advanced glycation end products, protein kinase C inhibitor, vascular epithelium growth factor inhibitor, antioxidants








Readers of this article also read:

Obesity management: Update on orlistat
Endothelial dysfunction in diabetes mellitus
Rationale for multiple risk intervention: The need to move from theory to practice
Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney
Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose–insulin homeostasis in animal models
Update on the diagnosis and management of acute kidney injury
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits
Erratum
Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University